Hospitals may use certain intravenous solutions made by Baxter Healthcare Corp. beyond the labeled expiration date due to the ongoing shortage of IV solutions used in critical care, the Food and Drug Administration announced today. Health care professionals should squeeze the bags before use and not use them if leaks are found, the agency said. The products should continue to be stored as labeled, and should be replaced and properly disposed of as soon as possible if replacement product becomes available during the extension period, FDA said.
 

Related News Articles

Headline
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.
Headline
The Centers for Disease Control and Prevention this week announced an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and Drug…
Headline
A federal court in Texas yesterday ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company…
Headline
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a…
Headline
The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).
Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.